Melatonin may prevent or reverse polycystic ovary syndrome in rats

Detalhes bibliográficos
Autor(a) principal: Lombardi,Leonardo Augusto
Data de Publicação: 2019
Outros Autores: Mattos,Leandro Sabará de, Simões,Ricardo Santos, Florencio-Silva,Rinaldo, Sasso,Gisela Rodrigues da Silva, Carbonel,Adriana Aparecida Ferraz, Simões,Manuel Jesus, Baracat,Edmund Chada, Soares Jr,José Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000701008
Resumo: SUMMARY OBJECTIVE To evaluate the ovarian effects of melatonin (Mel) in a rat model of polycystic-ovary-syndrome (PCOS) before and after permanent estrus induction. METHODS Thirty-two adult-female rats with regular estrous cycle were equally divided into four groups: 1) GCtrl – at estrous phase. 2) GPCOS - at permanent-estrous phase. 3) GMel1 – treated for 60 days with Mel (0.4 mg/Kg) during permanent estrus induction and 4) GMel2 – rats with PCOS and treated for 60 days with Mel. After that, the animals were euthanized, and the ovaries were removed and processed for paraffin embedding. Sections were stained with H.E. for histomorphometry or subjected to immunohistochemistry for Ki-67 and cleaved caspase-3 (Casp-3) detections. RESULTS The GPCOS showed lack of corpus luteum and several ovarian cysts, as well as interstitial-like cells. The presence of corpus luteum and a significant increase in primary and antral follicles were observed in Mel-treated groups, which also showed a decrease in the number of ovarian cysts and in the area occupied by interstitial-like cells. These results were more evident in GMel1. The percentage of Ki-67-positive cells was significantly higher in the Mel-treated groups, mainly in the GMel2, as compared to GPCOS. On the other hand, the percentage of Casp-3-positive cells was significantly lower in granulosa cells of GMel1, whereas it was significantly higher in the interstitial-like cells of GMel2, in comparison to GPCOS. CONCLUSION Melatonin administration prevents the permanent estrus state in the PCOS rat model. This effect is more efficient when melatonin is administered before permanent estrus induction.
id AMB-1_3a357110a5966442a4d4c067d5f87e6c
oai_identifier_str oai:scielo:S0104-42302019000701008
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Melatonin may prevent or reverse polycystic ovary syndrome in ratsOvaryMelatoninPolycystic Ovary SyndromeEstrous cycleRatsSUMMARY OBJECTIVE To evaluate the ovarian effects of melatonin (Mel) in a rat model of polycystic-ovary-syndrome (PCOS) before and after permanent estrus induction. METHODS Thirty-two adult-female rats with regular estrous cycle were equally divided into four groups: 1) GCtrl – at estrous phase. 2) GPCOS - at permanent-estrous phase. 3) GMel1 – treated for 60 days with Mel (0.4 mg/Kg) during permanent estrus induction and 4) GMel2 – rats with PCOS and treated for 60 days with Mel. After that, the animals were euthanized, and the ovaries were removed and processed for paraffin embedding. Sections were stained with H.E. for histomorphometry or subjected to immunohistochemistry for Ki-67 and cleaved caspase-3 (Casp-3) detections. RESULTS The GPCOS showed lack of corpus luteum and several ovarian cysts, as well as interstitial-like cells. The presence of corpus luteum and a significant increase in primary and antral follicles were observed in Mel-treated groups, which also showed a decrease in the number of ovarian cysts and in the area occupied by interstitial-like cells. These results were more evident in GMel1. The percentage of Ki-67-positive cells was significantly higher in the Mel-treated groups, mainly in the GMel2, as compared to GPCOS. On the other hand, the percentage of Casp-3-positive cells was significantly lower in granulosa cells of GMel1, whereas it was significantly higher in the interstitial-like cells of GMel2, in comparison to GPCOS. CONCLUSION Melatonin administration prevents the permanent estrus state in the PCOS rat model. This effect is more efficient when melatonin is administered before permanent estrus induction.Associação Médica Brasileira2019-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000701008Revista da Associação Médica Brasileira v.65 n.7 2019reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.65.7.1008info:eu-repo/semantics/openAccessLombardi,Leonardo AugustoMattos,Leandro Sabará deSimões,Ricardo SantosFlorencio-Silva,RinaldoSasso,Gisela Rodrigues da SilvaCarbonel,Adriana Aparecida FerrazSimões,Manuel JesusBaracat,Edmund ChadaSoares Jr,José Mariaeng2019-08-02T00:00:00Zoai:scielo:S0104-42302019000701008Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2019-08-02T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Melatonin may prevent or reverse polycystic ovary syndrome in rats
title Melatonin may prevent or reverse polycystic ovary syndrome in rats
spellingShingle Melatonin may prevent or reverse polycystic ovary syndrome in rats
Lombardi,Leonardo Augusto
Ovary
Melatonin
Polycystic Ovary Syndrome
Estrous cycle
Rats
title_short Melatonin may prevent or reverse polycystic ovary syndrome in rats
title_full Melatonin may prevent or reverse polycystic ovary syndrome in rats
title_fullStr Melatonin may prevent or reverse polycystic ovary syndrome in rats
title_full_unstemmed Melatonin may prevent or reverse polycystic ovary syndrome in rats
title_sort Melatonin may prevent or reverse polycystic ovary syndrome in rats
author Lombardi,Leonardo Augusto
author_facet Lombardi,Leonardo Augusto
Mattos,Leandro Sabará de
Simões,Ricardo Santos
Florencio-Silva,Rinaldo
Sasso,Gisela Rodrigues da Silva
Carbonel,Adriana Aparecida Ferraz
Simões,Manuel Jesus
Baracat,Edmund Chada
Soares Jr,José Maria
author_role author
author2 Mattos,Leandro Sabará de
Simões,Ricardo Santos
Florencio-Silva,Rinaldo
Sasso,Gisela Rodrigues da Silva
Carbonel,Adriana Aparecida Ferraz
Simões,Manuel Jesus
Baracat,Edmund Chada
Soares Jr,José Maria
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lombardi,Leonardo Augusto
Mattos,Leandro Sabará de
Simões,Ricardo Santos
Florencio-Silva,Rinaldo
Sasso,Gisela Rodrigues da Silva
Carbonel,Adriana Aparecida Ferraz
Simões,Manuel Jesus
Baracat,Edmund Chada
Soares Jr,José Maria
dc.subject.por.fl_str_mv Ovary
Melatonin
Polycystic Ovary Syndrome
Estrous cycle
Rats
topic Ovary
Melatonin
Polycystic Ovary Syndrome
Estrous cycle
Rats
description SUMMARY OBJECTIVE To evaluate the ovarian effects of melatonin (Mel) in a rat model of polycystic-ovary-syndrome (PCOS) before and after permanent estrus induction. METHODS Thirty-two adult-female rats with regular estrous cycle were equally divided into four groups: 1) GCtrl – at estrous phase. 2) GPCOS - at permanent-estrous phase. 3) GMel1 – treated for 60 days with Mel (0.4 mg/Kg) during permanent estrus induction and 4) GMel2 – rats with PCOS and treated for 60 days with Mel. After that, the animals were euthanized, and the ovaries were removed and processed for paraffin embedding. Sections were stained with H.E. for histomorphometry or subjected to immunohistochemistry for Ki-67 and cleaved caspase-3 (Casp-3) detections. RESULTS The GPCOS showed lack of corpus luteum and several ovarian cysts, as well as interstitial-like cells. The presence of corpus luteum and a significant increase in primary and antral follicles were observed in Mel-treated groups, which also showed a decrease in the number of ovarian cysts and in the area occupied by interstitial-like cells. These results were more evident in GMel1. The percentage of Ki-67-positive cells was significantly higher in the Mel-treated groups, mainly in the GMel2, as compared to GPCOS. On the other hand, the percentage of Casp-3-positive cells was significantly lower in granulosa cells of GMel1, whereas it was significantly higher in the interstitial-like cells of GMel2, in comparison to GPCOS. CONCLUSION Melatonin administration prevents the permanent estrus state in the PCOS rat model. This effect is more efficient when melatonin is administered before permanent estrus induction.
publishDate 2019
dc.date.none.fl_str_mv 2019-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000701008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302019000701008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.65.7.1008
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.65 n.7 2019
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212834282045440